BONDS: Sanofi issues bonds indexed on access to medicines | Photo credits: Sanofi Pasteur РAlexis Chezi̬re
PARIS (Agefi-Dow Jones)–The pharmaceutical company Sanofi announced on Thursday the successful launch of a double-tranche bond issue for a total amount of 1.5 billion euros.
This operation includes a bond issue indexed on a sustainable development indicator for a nominal amount of 650 million euros, linked to a commitment made by the company to improve access to essential medicines in low-income countries and lower middle income. These bonds will mature in April 2019 and will carry a fixed coupon of 1.25% per annum.
The second tranche relates to the issue of fixed-rate bonds, which will mature in April 2025, bearing interest at a fixed annual rate of 0.875%, for an amount of 850 million euros.
“The net proceeds from the issuance of these bonds will be used for general corporate purposes,” Sanofi said in a statement.
Dimitri Delmond, Agefi-Dow Jones; +33 (0)1 41 27 47 31; [email protected] ed: VLV
Agefi-Dow Jones The financial newswire
Dow Jones Newswires
March 31, 2022 01:20 ET (05:20 GMT)